Sun Pharmaceutical Industries Inc. is recalling one lot of Diclofenac Sodium (3%) Topical Gel, a prescription nonsteroidal anti-inflammatory drug (NSAID) used for skin conditions. The recall was initiated because the product's thickness (viscosity) was slightly lower than the required limit, which may affect how the gel is applied or absorbed. This recall affects a 100-gram tube manufactured by Taro Pharmaceuticals in Canada and distributed nationwide across the United States.
A lower-than-expected viscosity can cause the medication to be thinner than intended, potentially leading to inconsistent dosing or difficulty applying the correct amount of the gel to the skin.
You have 2 options:
Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada; Dist. by Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.